Net Cash Provided by (Used in) Operating Activities |
-22.1K |
USD |
+51.9% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
12.3K |
USD |
-62.6% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
4.45B |
shares |
+1.14% |
Q4 2024 |
Q3 2025 |
Common Stock, Shares, Issued |
3.83B |
shares |
+361% |
Q4 2024 |
Q3 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q3 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-397 |
USD |
+97% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
458K |
USD |
+349% |
Q4 2024 |
Q3 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
13.4K |
USD |
-92.3% |
Q4 2024 |
Q3 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.17 |
pure |
0% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
13.4K |
USD |
-92.3% |
Q4 2024 |
Q3 2025 |
Depreciation |
1.89K |
USD |
-48.9% |
Q4 2024 |
Q3 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-654K |
USD |
-417% |
Q4 2024 |
Q3 2025 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
Q3 2025 |
Additional Paid in Capital |
-21.7M |
USD |
|
Q4 2024 |
Q3 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
Q3 2025 |
Interest Expense |
2.72K |
USD |
|
Q2 2024 |
Q1 2025 |